ImmPACT designs logic gated CARs to address specific challenges in hematological and solid tumors.
Scientific approach
Developing cutting-edge CAR-T platform technologies to address antigen escape, ‘on-target, off-tumor’ toxicities and immunosuppressive microenvironment, all key challenges of current cell therapies in oncology.
Indications
Solid and hematological tumors
Team
Sumant Ramachandra, MD, PhD – CEO